Saved Bookmarks
| 1. |
Thrombopoietic growth factors in the treatment of immune thrombocytopenic purpura |
|
Answer» Both increased the PLATELET counts in HEALTHY subjects and in over two THIRDS of patients with ITP both before and after splenectomy; responses were maintained for at least 1 YEAR. Romiplostim and eltrombopag are now US Food and Drug Administration approved for the second-line treatment of patients with ITP. |
|